Blueprint Medicines (0HOJ.LSE) Q4 2023 Earnings

15FebConfirmed
Q4 2023
-2.04
-1.97
-1.89
-1.82

Details

Expected EPS
-2.039658
Actual EPS
-1.82
Surprise EPS
0.22
Surprise Percent
+10.77%

Description

Blueprint Medicines (0HOJ.LSE) has reported earnings of -1.82 per share for Q4 2023.

0 Comments

Share your thoughts